These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28234749)

  • 1. Role of MRI prebiopsy in men at risk for prostate cancer: taking off the blindfold.
    Bjurlin MA; Rosenkrantz AB; Taneja SS
    Curr Opin Urol; 2017 May; 27(3):246-253. PubMed ID: 28234749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediagnostic Risk Assessment with Prostate MRI and MRI-Targeted Biopsy.
    Bjurlin MA; Taneja SS
    Urol Clin North Am; 2017 Nov; 44(4):535-546. PubMed ID: 29107270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study.
    Washino S; Kobayashi S; Okochi T; Kameda T; Konoshi T; Miyagawa T; Takayama T; Morita T
    BMC Urol; 2018 May; 18(1):51. PubMed ID: 29843694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.
    Schoots IG; Roobol MJ; Nieboer D; Bangma CH; Steyerberg EW; Hunink MG
    Eur Urol; 2015 Sep; 68(3):438-50. PubMed ID: 25480312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Magnetic Resonance Imaging-directed Biopsy Strategies for Changing the Paradigm of Prostate Cancer Diagnosis.
    Schoots IG; Padhani AR; Rouvière O; Barentsz JO; Richenberg J
    Eur Urol Oncol; 2020 Feb; 3(1):32-41. PubMed ID: 31706946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
    Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
    Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
    Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
    BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.
    Yarlagadda VK; Lai WS; Gordetsky JB; Porter KK; Nix JW; Thomas JV; Rais-Bahrami S
    Diagn Interv Radiol; 2018; 24(3):115-120. PubMed ID: 29770762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI to guide biopsies or avoid biopsies?
    Winoker JS; Pinto PA; Rastinehad AR
    Curr Opin Urol; 2018 Nov; 28(6):522-528. PubMed ID: 30239414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
    Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
    Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
    Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
    Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.
    Komai Y; Numao N; Yoshida S; Matsuoka Y; Nakanishi Y; Ishii C; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    J Urol; 2013 Sep; 190(3):867-73. PubMed ID: 23542406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
    Recabal P; Assel M; Sjoberg DD; Lee D; Laudone VP; Touijer K; Eastham JA; Vargas HA; Coleman J; Ehdaie B
    J Urol; 2016 Aug; 196(2):374-81. PubMed ID: 26920465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of real-time elastography on magnetic resonance imaging/ultrasound fusion guided biopsy in patients with prior negative prostate biopsies.
    Brock M; Löppenberg B; Roghmann F; Pelzer A; Dickmann M; Becker W; Martin-Seidel P; Sommerer F; Schenk L; Palisaar RJ; Noldus J; von Bodman C
    J Urol; 2015 Apr; 193(4):1191-7. PubMed ID: 25451832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MRI in low-risk prostate cancer: finding the wolf in sheep's clothing or the sheep in wolf's clothing?
    Schoots IG; Moore CM; Rouvière O
    Curr Opin Urol; 2017 May; 27(3):238-245. PubMed ID: 28306604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.
    Moore CM; Kasivisvanathan V; Eggener S; Emberton M; Fütterer JJ; Gill IS; Grubb Iii RL; Hadaschik B; Klotz L; Margolis DJ; Marks LS; Melamed J; Oto A; Palmer SL; Pinto P; Puech P; Punwani S; Rosenkrantz AB; Schoots IG; Simon R; Taneja SS; Turkbey B; Ukimura O; van der Meulen J; Villers A; Watanabe Y;
    Eur Urol; 2013 Oct; 64(4):544-52. PubMed ID: 23537686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results.
    Wysock JS; Mendhiratta N; Zattoni F; Meng X; Bjurlin M; Huang WC; Lepor H; Rosenkrantz AB; Taneja SS
    BJU Int; 2016 Oct; 118(4):515-20. PubMed ID: 26800439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies.
    Mendhiratta N; Meng X; Rosenkrantz AB; Wysock JS; Fenstermaker M; Huang R; Deng FM; Melamed J; Zhou M; Huang WC; Lepor H; Taneja SS
    Urology; 2015 Dec; 86(6):1192-8. PubMed ID: 26335497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
    Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.